Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.

Détails

ID Serval
serval:BIB_0A234F98FD6C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
Périodique
Anticancer Research
Auteur⸱e⸱s
Maggiorella L., Wen B., Frascogna V., Opolon P., Bourhis J., Deutsch E.
ISSN
0250-7005 (Print)
ISSN-L
0250-7005
Statut éditorial
Publié
Date de publication
2005
Peer-reviewed
Oui
Volume
25
Numéro
6B
Pages
4357-4362
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
Ritonavir, a protease inhibitor, has been successfully applied in the treatment of HIV infection. Reports of dramatic improvement of AIDS-related cancers, such as primary central system lymphoma after radiation therapy as well as Kaposi's sarcoma, led to the recent discovery of the "non viral" antitumor activity of HIV protease inhibitors. This study was designed to detect the antitumor effect of Ritonavir when combined with ionizing radiation both in vitro and in vivo in the HEP-2 head and neck carcinoma model. Inhibition of tumor growth was observed when mice were treated with Ritonavir alone and this effect was enhanced when combined with ionizing radiation. No adverse effect or significant toxicity in the hosts' body weights was seen between the different treatment and control groups throughout the experiments. A marked antiproliferation effect of the combination was observed in vitro. A marked reduction of angiogenesis was detected within the tumor sections from the Ritonavir combined with irradiation group as compared with the Ritonavir or irradiation alone groups. Western blot analysis showed that apoptosis was induced by an increased expression of Bax and decreased expression of Bcl-2 after treatment with Ritonavir and ionizing radiation. Thus, the antitumor effect of the latter combination is associated with the enhancement of radiation-induced apoptosis and inhibition of angiogenesis. These data suggested that Ritonavir could clinically improve the tumor response to radiation therapy, especially in head and neck carcinoma.
Mots-clé
Animals, Apoptosis/drug effects, Apoptosis/radiation effects, Carcinoma, Squamous Cell/blood supply, Carcinoma, Squamous Cell/drug therapy, Cell Growth Processes/drug effects, Cell Growth Processes/radiation effects, Cell Line, Tumor, Combined Modality Therapy, Female, Head and Neck Neoplasms/blood supply, Head and Neck Neoplasms/drug therapy, Humans, Mice, Mice, Nude, Neovascularization, Pathologic/drug therapy, Neovascularization, Pathologic/pathology, Radiation-Sensitizing Agents/pharmacology, Ritonavir/pharmacology, Xenograft Model Antitumor Assays
Pubmed
Web of science
Création de la notice
01/12/2014 17:40
Dernière modification de la notice
20/08/2019 12:32
Données d'usage